PRKN and Parkinson disease: Parkin-K71P was made by mutation of the corresponding amino acid based on human Parkinson's pathogenic mutant Parkin-R42P (47), leading to the destruction of Ubl structure, thus preventing the interaction between Parkin and substrate protein (Fig. 1F).